€38.00 – €99.00
Guanfacine HCl powder
SKU: guanfacine
ACTIVE INGREDIENT: Guanfacine HCl
ADDITIONAL INGREDIENTS: –
OTHER NAMES: BS 100 141; BS-100-141; BS100141; Estulic; Guanfacine; Guanfacine Hydrochloride; Guanfacine Monohydrochloride; Hydrochloride, Guanfacine; Lon798; Monohydrochloride, Guanfacine; Tenex
CAS NUMBER: 29110-48-0
ATC CODE: C02AC02
FORMULA: C9H9Cl2N3O
MOLAR MASS: 246.096 g/mol
ITEM TYPE: powder
QUANTITY PER PACK: 100 and 500 milligrams
STORAGE: Store in a cool and dry place. Keep away from direct sunlight and heat. Keep out of reach of children.
SCOOPS: This product includes a measuring scoop.
The product is not intended for human use. For laboratory use only.
Guanfacine is FDA-approved as monotherapy or augmentation with stimulants to treat attention deficit hyperactivity disorder (ADHD). Unlike stimulant medications, guanfacine is regarded as having no abuse potential, and may even be used to reduce abuse of drugs including nicotine and cocaine. It is also FDA approved to treat high blood pressure. Guanfacine can offer a synergistic enhancement of stimulants such as amphetamines and methylphenidate for treating ADHD, and in many cases can also help control the side effect profile of stimulant medications. For ADHD, it is claimed that guanfacine helps individuals better control behavior, inhibit inappropriate distractions and impulses, and inhibit inappropriate aggressive impulses. Systematic reviews and meta-analyses have found guanfacine to be effective in the treatment of ADHD in both children and adults, with a moderate effect size found in adults (Hedges’ g = -0.66). A systematic review and meta-analysis also found that guanfacine reduced oppositional behavior in children and adolescents with ADHD who also had or did not also have oppositional defiant disorder, with a small-to-moderate effect size. In any case, guanfacine and other α2-adrenergic receptor agonists are considered to be less effective than stimulants in the treatment of ADHD.
Guanfacine is also used off-label to treat tic disorders, anxiety disorders such as generalized anxiety disorder, and PTSD. Guanfacine and other α2A-adrenergic receptor agonists have anxiolytic-like action, thereby reducing the emotional responses of the amygdala, and strengthening prefrontal cortical regulation of emotion, action, and thought. These actions arise from both inhibition of stress-induced catecholamine release, and from prominent, post-synaptic actions in the prefrontal cortex. Due to its prolonged elimination half-life, it also has been seen to improve sleep interrupted by nightmares in PTSD patients. All of these actions likely contribute to the relief of the hyperarousal, re-experiencing of memory, and impulsivity associated with PTSD. Guanfacine appears to be especially helpful in treating children who have been traumatized or abused.
Source: Wikipedia